- Joined
- Feb 15, 2003
- Messages
- 259
- Reaction score
- 0
I came across a question in the Qbook that I can't make sense of.
My friend and I have been going over it and keep running into road blocks. If one were given Norepi, wouldn't the B1 activity cause an increased heart rate, not decreased as the correct answer says. I know there would be eventual refelx bradycardia with Norepi, but the graph has the MAP going up simultaneously with the HR going down. I can't see how this could happen. Additionally, I don't see how hexamthonium has such a specific effect as they indicate it has. As it is a gangloin blocker, I don't see how it decreases MAP, but increases HR. Maybe my reading comprehension skills aren't so good these days, and the explanation for the answer is sufficient. Can anyone explain this in another way to help me and my classmate out?
My friend and I have been going over it and keep running into road blocks. If one were given Norepi, wouldn't the B1 activity cause an increased heart rate, not decreased as the correct answer says. I know there would be eventual refelx bradycardia with Norepi, but the graph has the MAP going up simultaneously with the HR going down. I can't see how this could happen. Additionally, I don't see how hexamthonium has such a specific effect as they indicate it has. As it is a gangloin blocker, I don't see how it decreases MAP, but increases HR. Maybe my reading comprehension skills aren't so good these days, and the explanation for the answer is sufficient. Can anyone explain this in another way to help me and my classmate out?